426 related articles for article (PubMed ID: 23354040)
21. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
[TBL] [Abstract][Full Text] [Related]
22. Löfgren Syndrome on 18F-FDG PET/CT: An Acute Manifestation of Sarcoidosis.
Tol SJM; van der Zant FM; Knol RJJ; Wondergem M; Broos WAM
Clin Nucl Med; 2022 Jan; 47(1):61-62. PubMed ID: 34874349
[TBL] [Abstract][Full Text] [Related]
23. Diffuse renal (18)F-FDG uptake of a patient with fever of unknown origin revealed sarcoidosis.
Toyonaga T; Manabe O; Gaertner FC; Nakagaki T; Nishio S; Suzuki A; Tamaki N
Clin Nucl Med; 2014 Jul; 39(7):648-9. PubMed ID: 24873783
[TBL] [Abstract][Full Text] [Related]
24. Laryngeal sarcoidosis detected by FDG positron emission tomography.
Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
Clin Nucl Med; 2008 Dec; 33(12):878-9. PubMed ID: 19033796
[TBL] [Abstract][Full Text] [Related]
25. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
[TBL] [Abstract][Full Text] [Related]
27. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
[TBL] [Abstract][Full Text] [Related]
28. Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
[TBL] [Abstract][Full Text] [Related]
29. F-18 FDG PET/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus.
Asabella AN; Gatti P; Notaristefano A; Iuele F; Altini C; Rubini G
Clin Nucl Med; 2011 Sep; 36(9):795-7. PubMed ID: 21825853
[No Abstract] [Full Text] [Related]
30. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
31. Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient.
Han EJ; Jang YS; Lee IS; Lee JM; Kang S; Kim HS
J Korean Med Sci; 2013 Sep; 28(9):1399-402. PubMed ID: 24015050
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of pulmonary sarcoidosis.
Israel-Biet D; Valeyre D
Curr Opin Pulm Med; 2013 Sep; 19(5):510-5. PubMed ID: 23880701
[TBL] [Abstract][Full Text] [Related]
33. Be aware of disseminated sarcoidosis with diffuse subcutaneous nodules on F-18 FDG PET.
Rafiei P; Vijayakumar V
Clin Nucl Med; 2011 Jun; 36(6):e42-4. PubMed ID: 21552015
[TBL] [Abstract][Full Text] [Related]
34. Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
El Hammoumi M; El Marjany M; Moussaoui D; Doudouh A; Mansouri H; Kabiri el H
Arch Bronconeumol; 2015 Jul; 51(7):e33-5. PubMed ID: 25294405
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous Manifestation of Sarcoidosis in Lower-Back Tattoo With Increased Uptake of 18F-FDG.
Grosse J; Menhart K; Schmidbauer B; Hellwig D
Clin Nucl Med; 2018 Jun; 43(6):454-455. PubMed ID: 29538031
[TBL] [Abstract][Full Text] [Related]
36. FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis.
Cheng CY; Huang WS; Shen DH; Fan YM; Hsu HH; Cherng SC; Lee SC
Clin Nucl Med; 2007 Feb; 32(2):117-21. PubMed ID: 17242565
[No Abstract] [Full Text] [Related]
37. Refractory polymyalgia rheumatica as presenting manifestation of large-vessel vasculitis associated to sarcoidosis. Successful response to adalimumab.
Bejerano C; Blanco R; González-Vela C; Agüero R; Carril JM; González-Gay MA
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S94-7. PubMed ID: 22410180
[TBL] [Abstract][Full Text] [Related]
38. Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis.
Tannen BL; Ghesani NV; Frohman L; Eichler JD; Maldjian PD; Chu DS
Ocul Immunol Inflamm; 2008; 16(1):25-7. PubMed ID: 18379938
[TBL] [Abstract][Full Text] [Related]
39. FDG-PET Scan in Sarcoidosis: Clinical and Imaging Indications.
Maccarone MT
Curr Med Imaging Rev; 2019; 15(1):4-9. PubMed ID: 31964321
[TBL] [Abstract][Full Text] [Related]
40. Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis.
Sobic-Saranovic DP; Grozdic IT; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko VM; Saranovic DZ; Pavlovic SV; Obradovic VB
Clin Nucl Med; 2013 Jul; 38(7):516-21. PubMed ID: 23486337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
